308 related articles for article (PubMed ID: 30617961)
1. Early
Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET/CT imaging of insulinoma revisited.
Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
[TBL] [Abstract][Full Text] [Related]
3. Clinical Value of
Nakuz TS; Berger E; El-Rabadi K; Wadsak W; Haug A; Hacker M; Karanikas G
Anticancer Res; 2018 Jan; 38(1):353-358. PubMed ID: 29277794
[TBL] [Abstract][Full Text] [Related]
4. Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Detour J; Pierre A; Boisson F; Kreutter G; Lavaux T; Namer IJ; Kessler L; Brasse D; Marchand P; Imperiale A
J Nucl Med; 2017 Jan; 58(1):36-41. PubMed ID: 27609787
[TBL] [Abstract][Full Text] [Related]
5. Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Imperiale A; Bahougne T; Goichot B; Bachellier P; Taïeb D; Namer IJ
Clin Nucl Med; 2015 Aug; 40(8):682-4. PubMed ID: 25549347
[TBL] [Abstract][Full Text] [Related]
6. Carbidopa-assisted
Helali M; Addeo P; Heimburger C; Detour J; Goichot B; Bachellier P; Namer IJ; Taïeb D; Imperiale A
Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
[TBL] [Abstract][Full Text] [Related]
7. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
8. O-(2-
Imperiale A; Boisson F; Kreutter G; Goichot B; Namer IJ; Bachellier P; Laquerriere P; Kessler L; Marchand P; Brasse D
Nucl Med Biol; 2017 Oct; 53():21-28. PubMed ID: 28793277
[TBL] [Abstract][Full Text] [Related]
9. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Tessonnier L; Sebag F; Ghander C; De Micco C; Reynaud R; Palazzo FF; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
J Clin Endocrinol Metab; 2010 Jan; 95(1):303-7. PubMed ID: 19915018
[TBL] [Abstract][Full Text] [Related]
10. Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased
Somme F; Montaz-Rosset MS; Averous G; Deur J; Goichot B; Bachellier P; Addeo P; Imperiale A
Clin Endocrinol (Oxf); 2020 Jul; 93(1):78-81. PubMed ID: 32314437
[TBL] [Abstract][Full Text] [Related]
11. Value of
Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
van Beek AP; de Heide LJ; van Ginkel B; Slart RH; van der Horst-Schrivers AN; Boellaard R; de Vries EG; Noordzij W; Glaudemans AW
Clin Nucl Med; 2017 Mar; 42(3):163-168. PubMed ID: 28005639
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
15. Adrenal tracer uptake by
Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769
[TBL] [Abstract][Full Text] [Related]
16. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.
Calabrò D; Argalia G; Ambrosini V
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297381
[TBL] [Abstract][Full Text] [Related]
17. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
Prasad V; Sainz-Esteban A; Arsenic R; Plöckinger U; Denecke T; Pape UF; Pascher A; Kühnen P; Pavel M; Blankenstein O
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1593-600. PubMed ID: 26923247
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison between
Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
